GlaxoSmithKline and NeuroSearch to Investigate CNS Diseases

By Business Review Editor

Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)

Published: 4 Feb-2004

DOI: 10.3833/pdr.v2004.i44.828     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

GlaxoSmithKline formed a 5 year research and development alliance with NeuroSearch for several research programs for treating CNS diseases such as depression, anxiety and schizophrenia in a deal worth up to €82 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details